Benchmark International

Benchmarks Exclusive Opportunities

  • Home
  • Opportunities
  • Buyer Profile
  • About
    • About Us
    • From the Chairman
    • Offices
  • Blog
  • Contact
Primary
  • Home
  • Opportunities
  • Buyer Profile
  • About
    • About Us
    • From the Chairman
    • Offices
  • Blog
  • Contact
  • Home
  • About Us
  • Blog
  • Contact Us
  • From the Chairman
  • Offices
  • Opportunities
  • Stats Dashboard
    • Listing Stats
    • Your Listings

Contract Research Organization with Developed Patent Pending Technology BN000045896

Illinois, Midwest US, US
1M-5MUnder 500k Care, Health & Medical, Healthcare, Laboratory
Add Photos
TEASER
CLIENT CODE: BN000045896
REVENUE/TURNOVER: 3,000,000
EBITDA: 460,000
 
Interested? Contact Us
edeslauriers@benchmarkintl.com
Contract Research Organization with Developed Patent Pending Technology BN000045896

Etienne Deslauriers

interested in this opportunity?
Browse My Listings

The company, offers advanced sensory scientific expertise, equipment, and biomedical research services to its clients. The company provides world-class preclinical (animal) sensory research as a specialty contract research organization (CRO) focusing on auditory studies, and provides advanced biomedical and animal research facility monitoring solutions. Both divisions of the company are innovative disruptors in their respective industry spaces.

Key Aspects

  • Global operations allow the company to service a large pool of clients
  • Lead scientist has over 22 years of experience studying auditory functions
  • Diverse revenue streams provide consistent work and research project opportunities
  • State-of-the-art facility monitoring device that is patent pending places the company at the forefront of technological innovation in the facility monitoring industry

Opportunities

  • Pursue expansion of subscription-based model for the company’s proprietary device to increase recurring revenue
  • Increase brand awareness in European markets where animal research guidelines are more progressive and need advanced monitoring solutions
  • Develop new research offerings capitalizing on the investment of the newly built miniature swine facility
  • Obtain capacity to perform Good Laboratory Practice (GLP) studies
  • Patent the company’s proprietary device in order to protect intellectual property

Headquartered

  • Midwest United States

Current Markets

  • The company serves domestic and international clients in pharmaceutical, biotechnology, and university markets.

Real Estate

  • The company owns and operates from a 10,680 sq. ft. facility

Shareholder Objectives

  • The owners are seeking a buyer to help facilitate the company’s growth and are open to various deal structures.

You Might Also Like

    AMERICAS HQ

    4030 West Boy Scout Blvd. Suite 500
    Tampa, FL 33609
    +1 813 898 2350
    US@Benchmarkintl.com

    Europe HQ

    101 Park Dr., Milton Park
    Oxfordshire, OX14 4RY
    +44 (0)1865 410 050
    UK@Benchmarkintl.com

    AFRICA HQ

    Ground Floor, Runway 01, Airport Office Park
    Cape Town International Airport, Cape Town, 7525
    +27 21 300 2055
    Africa@Benchmarkintl.com

    Copyright Benchmark International © 2022-2023. All Rights Reserved
    • LinkedIn
    • Twitter
    • Instagram
    • Vimeo
    • YouTube

    Login

    Lost your password?